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SET
Surgical treatment of bicuspid aortic valve-associated conditions is not a particular technical
challenge. However, the scientific basis for management criteria is still rudimentary and persistent
gaps in knowledge determine inconsistencies in surgical practice and lack of patient-tailored
approaches. This review focuses on controversial or unexplored aspects of bicuspid disease.)
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110A The Journal of Thoracic an758 Early and 1-year outcomes of aortic root surgery in patients with Marfan
syndrome: A prospective, multicenter, comparative study(continued on page 11A
d Cardiovascular Surgery c June 2014Joseph S. Coselli, MD, Irina V. Volguina, PhD, Scott A. LeMaire, MD, Thoralf M. Sundt, MD,
Heidi M. Connolly, MD, Elizabeth H. Stephens, MD, PhD, Hartzell V. Schaff, MD,
Dianna M. Milewicz, MD, PhD, Luca A. Vricella, MD, Harry C. Dietz, MD,
Charles G. Minard, PhD, and D. Craig Miller, MD, on behalf of the Aortic Valve Operative
Outcomes in Marfan Patients Study Group, Houston, Tex, Boston, Mass, Rochester, Minn,
Stanford, Calif, and Baltimore, MdAmong 316 patients with MFS, the 1-year survival and valve-related morbidity and mortality did
not differ between those who underwent AVS or AVR aortic root replacement. A greater unadjusted
rate of nonstructural valve dysfunction ($2+ aortic regurgitation) after AVS root replacement
mandates longer follow-up to determine this procedure’s durability.1768 Valve-sparing aortic root replacement and remodeling with complex aortic
valve reconstruction in children and young adults with moderate or severe
aortic regurgitation
Patrick O. Myers, MD, Pedro J. del Nido, MD, Sitaram M. Emani, MD, Gerald R. Marx, MD, and
Christopher W. Baird, MD, Boston, Mass, and Geneva, SwitzerlandThirty-four patients underwent valve-sparing root and valve reconstruction from 2000 to 2012.
Freedom from structural valve deterioration was 70% at 1 year and stable thereafter, but was
significantly worse in the reimplantation group. Valve-sparing root and valve reconstruction
can be done with low operative risk and allows valve preservation in most patients.1777 Hybrid versus Norwood procedure for hypoplastic left heart syndrome:
Contemporary series from a single center
Alexander A. Brescia, MS, Saadeh Jureidini, MD, Saar Danon, MD, Eric Armbrecht, PhD,
Andrew C. Fiore, MD, and Charles B. Huddleston, MD, St Louis, MoWe compared the outcomes of the Norwood and hybrid procedures for neonates with HLHS.
We found no advantage for the hybrid approach compared with the conventional Norwood
procedure for first stage palliation.1783 Outcomes of slide tracheoplasty in 101 children: A 17-year single-center
experience
Colin R. Butler, MRCS, Simone Speggiorin, MD, Friso M. Rijnberg, BSc, Derek J. Roebuck, FRCR,
Nagarajan Muthialu, FRCS, Richard J. Hewitt, FRCS, and Martin J. Elliott, MD, FRCS, London,
United KingdomThis study describes the surgical results from slide tracheoplasty in children with long segment
tracheal stenosis and highlights preoperative bronchomalacia as a significant risk factor for
death and postoperative stenting.)






L1791 Risk factors for prolonged length of stay after the stage 2 procedure in the
single-ventricle reconstruction trial(continued on page 12A
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 6 11ACH
DSteven M. Schwartz, MD, Minmin Lu, MS, Richard G. Ohye, MD, Kevin D. Hill, MD,
Andrew M. Atz, MD, Maryam Y. Naim, MD, Ismee A. Williams, MD, MS,
Caren S. Goldberg, MD, MS, Alan Lewis, MD, Frank Pigula, MD, Peter Manning, MD,
Christian Pizarro, MD, Paul Chai, MD, Rachel McCandless, MD,
Carolyn Dunbar-Masterson, BSN, Jonathan R. Kaltman, MD, Kirk Kanter, MD,
Lynn A. Sleeper, ScD, Julie V. Schonbeck, MSN, C-PNP, and Nancy Ghanayem, MD,
for the Pediatric Heart Network Investigators, Toronto, Ontario, Canada, Watertown and Boston,
Mass, Ann Arbor, Mich, Durham, NC, Charleston, SC, Philadelphia, Pa, New York, NY, Los
Angeles, Calif, Cincinnati, Ohio, Wilmington, Del, Tampa, Fla, Salt Lake City, Utah,
Bethesda, Md, Atlanta, Ga, and Milwaukee, WisG
TSHospital length of stay after the stage 2 procedure in the single-ventricle reconstruction trial cohort
is independently associated with post-Norwood length of stay, pulmonary artery stenoses, and
nonelective timing of the stage 2 procedure. Shunt type was not associated with any hospital
outcomes.1799 Is the liberal use of preoperative 3-dimensional imaging and presternotomy
femoral cutdown beneficial in reoperative adult congenital heart surgery?
Brian E. Kogon, MD, William Daniel, MD, Katherine Fay, MD, and Wendy Book, MD, Atlanta, GaA
CDIn adult congenital heart surgery, unique anatomy canmake reoperative sternotomy and the conduct
of cardiopulmonary bypass challenging. Based on the preoperative history and 3-dimensional
imaging, a selective approach to presternotomy femoral intervention may be beneficial.General Thoracic
Surgery (GTS)
1805 Prognostic analysis of salvage esophagectomy after definitive
chemoradiotherapy for esophageal squamous cell carcinoma: The importance
of lymphadenectomy
Shaohua Wang, MD, Yuji Tachimori, MD, Nobukazu Hokamura, MD, Hiroyasu Igaki, MD,
Hidetsugu Nakazato, MD, and Takayoshi Kishino, MD, Tokyo, Japan, and Shanghai, ChinaMPFor salvage esophagectomy to be beneficial after definitive chemoradiotherapy for squamous cell
cancer, tumor recurrence as the surgical indication, complete resection, and localized disease are
necessary. Mediastinal lymphadenectomy is also important. Total mediastinal lymphadenectomy of
at least 15 mediastinal nodes is recommended based on the present study.Commentary 1812 Salvage esophagectomy: ‘‘We made too many wrong mistakes’’
Thomas W. Rice, MD, and Eugene H. Blackstone, MD, Cleveland, OhioB
S1813 Use of virtual assisted lung mapping (VAL-MAP), a bronchoscopic multispot
dye-marking technique using virtual images, for precise navigation of
thoracoscopic sublobar lung resectionET
/Masaaki Sato, MD, PhD, Mitsugu Omasa, MD, PhD, Fengshi Chen, MD, PhD,
Toshihiko Sato, MD, PhD, Makoto Sonobe, MD, PhD, Toru Bando, MD, PhD, and
Hiroshi Date, MD, PhD, Kyoto, JapanTXVAL-MAP is a novel bronchoscopic preoperative lung marking technique using 3-dimensional
virtual images to create concurrent multiple dye markings on the lung with minimal complications.
In addition to conventional marking techniques for tumor localization, VAL-MAP provides
‘‘geometric information’’ to navigate precise thoracoscopic sublobar lung resection and obtain
sufficient resection margins.)














TX112A The Journal of Thoracic an820 Role of lymphatic invasion in the prognosis of patients with clinical
node-negative and pathologic node-positive lung adenocarcinoma(continued on page 13A
d Cardiovascular Surgery c June 2014Takahiro Mimae, MD, PhD, Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,
Tomoharu Yoshiya, MD, Yuta Ibuki, MD, Kei Kushitani, MD, PhD, Yukio Takeshima, MD, PhD,
Haruhiko Nakayama, MD, PhD, Sakae Okumura, MD, PhD, Masahiro Yoshimura, MD, PhD, and
Morihito Okada, MD, PhD, Hiroshima, Yokohama, Tokyo, and Akashi, JapanLymphatic invasion, which is not always present in node-positive adenocarcinoma, is an important
prognostic variable in both pathologic node positive and node negative patients with clinical stage
IA lung adenocarcinomas.1827 Endobronchial therapy with a thulium fiber laser (1940 nm)
Wolfgang Gesierich, MD, Frank Reichenberger, MD, Andreas Fertl, MD, Karl Haeussinger, MD,and Ronald Sroka, PhD, Gauting and Muenchen, GermanyThe thulium fiber laser emitting at 1940 nm has enhanced absorption in tissuewater. Endobronchial
laser therapy for airway stenosis including in-stent tissue at this wavelength is safe, feasible, and
highly versatile, promising improvements in laser bronchoscopy.Acquired Cardiovascular
Disease (ACD)
1833 Myectomy and mitral repair through the left atrium in hypertrophic
obstructive cardiomyopathy: The preferred approach for contemporary
surgical candidates?
Herbert Gutermann, MD, Matteo Pettinari, MD, Christiaan Van Kerrebroeck, MD, PhD,
Margot Vander Laenen, MD, Kim Engelen, MD, Tom Fret, MD, and Robert A. Dion, MD, PhD,
Genk, BelgiumSeptal myectomy through the AML, with subsequent leaflet augmentation, allows for complete
alleviation of the peak intraventricular gradients in patients with HOCM and diffuse hypertrophy
extending to the midportion of the left ventricle or beyond. The technique also allows for correction
of mitral and subvalvular abnormalities.1837 Surgery for infective endocarditis complicated by cerebral embolism: A
consecutive series of 375 patients
Martin Misfeld, MD, PhD, Felix Girrbach, MD, Christian D. Etz, MD, PhD, Christian Binner, MD,
Konstantin V. Aspern, MD, Pascal M. Dohmen, MD, PhD, Piroze Davierwala, MD,
Bettina Pfannmueller, MD, PhD, Michael A. Borger, MD, PhD, and
Friedrich-Wilhelm Mohr, MD, PhD, Leipzig, GermanyOut of 1571 patients receiving operation for infective endocarditis at our institution, we identified
375 patients with septic cerebral embolism. Cerebral embolism was a predictor for an inferior
short- and long-term outcome, but outcome does not differ in patients with symptomatic versus
silent embolism.)






L1847 Dynamic characterization of aortic annulus geometry and morphology with
multimodality imaging: Predictive value for aortic regurgitation after
transcatheter aortic valve replacement(continued on page 14A
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 6 13AAhmad Masri, MD, Paul Schoenhagen, MD, Lars Svensson, MD, PhD, Samir R. Kapadia, MD,
Brian P. Griffin, MD, E. Murat Tuzcu, MD, and Milind Y. Desai, MD, Cleveland, OhioCH
DSPatients undergoing TAVR, as compared with those undergoing surgical AVR, have higher
postprocedural AR associated with higher mortality. We studied 87 patients with high-risk severe
aortic stenosis (81 6 10 years; 54% men) who underwent preprocedural echocardiography and
contrast-enhanced (4-dimensional) multidetector computed tomography of the aortic root,
followed by TAVR (n5 55) or surgical AVR (n5 32). A higher proportion of patients had$mild
AR in the TAVR versus the surgical AVR group (58% vs 34%; P, .03). In TAVR patients, reduced
annular deformation (P 5 .01) predicted postprocedural AR, in addition to prosthesis undersizing
(P 5 .03) and higher annular calcification (P 5 .03).1855 Trends in repair of intact and ruptured descending thoracic aortic aneurysms
in the United States: A population-based analysisG
TArman Kilic, MD, Ashish S. Shah, MD, James H. Black III, MD, Glenn J. R. Whitman, MD,
David D. Yuh, MD, Duke E. Cameron, MD, and John V. Conte, MD, Baltimore, Md, and
New Haven, ConnA
CDThis study provides a population-based analysis of more than 20,000 patients undergoing
descending thoracic aortic aneurysm repair in the United States from 1998 to 2008. Despite an
increasing comorbidity burden, rates of repair increased and operative mortality decreased for
intact and ruptured DTAAs, in part because of the increasing adoption of endovascular approaches.1861 Early patency rate and fate of reattached intercostal arteries after repair of
thoracoabdominal aortic aneurysms
Atsushi Omura, MD, Katsuhiro Yamanaka, MD, Shunsuke Miyahara, MD,
Toshihito Sakamoto, MD, Takeshi Inoue, MD, Kenji Okada, MD, and Yutaka Okita, MD, Kobe,
JapanPMWe investigated the early patency and fate of reattached intercostal arteries after repair of
thoracoabdominal aortic aneurysms. Aortic patch anastomosis might offer better patency rates and
prevent spinal cord ischemic injury compared with graft interposition. Large blocks of aortic wall
reconstruction might have risk of late dilation.1868 Risk scores for predicting mortality after surgical ventricular reconstruction
for ischemic cardiomyopathy: Results of a Japanese multicenter studyET
/B
SSatoru Wakasa, MD, PhD, Yoshiro Matsui, MD, PhD, Tadashi Isomura, MD, PhD,
Shuichiro Takanashi, MD, PhD, Atsushi Yamaguchi, MD, PhD, Tatsuhiko Komiya, MD,
Yasunori Cho, MD, PhD, Junjiro Kobayashi, MD, PhD, Hitoshi Yaku, MD, PhD,
Kiyokazu Kokaji, MD, PhD, Hirokuni Arai, MD, PhD, and Yoshiki Sawa, MD, PhD, Sapporo,
Hayama, Tokyo, Saitama, Kurashiki, Isehara, Osaka, and Kyoto, JapanWe assessed 596 patients who underwent surgical ventricular reconstruction for ischemic heart
failure in 11 Japanese cardiovascular hospitals between 2000 and 2010. Four independent
predictors for postoperative mortality were identified, and a prognostic model was developed using
a risk score calculated for each patient.)
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TX114A The Journal of Thoracic an875 Prediction of acute kidney injury within 30 days of cardiac surgery(continued on page 15A
d Cardiovascular Surgery c June 2014Shu Yi Ng, MBBS, Masoumeh Sanagou, MSc, Rory Wolfe, PhD,
Andrew Cochrane, MBBS, MPH, MEpid, FRACS, FRCS (CTh),
Julian A. Smith, MS, FRACS, and Christopher Michael Reid, PhD,
Melbourne, AustraliaTwo separate models, including either preoperative or pre-, peri-, and early postoperative risk
factors for AKI after cardiac surgery were developed for Australian patients using the registry data
from 2001 to 2009. The models yielded good discrimination ability with an area under the receiver
operating characteristic curve of 0.77 and 0.81.1884 Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic
position
Amedeo Anselmi, MD, Erwan Flecher, MD, PhD, Vito Giovanni Ruggieri, MD, PhD,
Majid Harmouche, MD, Thierry Langanay, MD, Herve Corbineau, MD,
Jean-Philippe Verhoye, MD, PhD, and Alain Leguerrier, MD, Rennes, FranceLong-term clinical follow-up data for 1007 Medtronic Mosaic aortic prostheses revealed optimal
actual freedom from structural degeneration in a single-institution study. The rate of structural
degeneration was greater in patients younger than 70 years at implantation, but other valve-related
adverse events were not age dependent. Younger patients should be correctly informed regarding
the expected duration of the bioprostheses.1892 Hemodynamic performance and outcome of percutaneous versus surgical
stentless bioprostheses for aortic stenosis with anticipated patient–prosthesis
mismatch
Arie Finkelstein, MD, Arie Lorin Schwartz, MD, Gideon Uretzky, MD, Shmuel Banai, MD,
Gad Keren, MD, Amir Kramer, MD, and Yan Topilsky, MD, Tel-Aviv, IsraelIn patients with expected PPM, TAVR showed better immediate gradients than did SAVR, but they
were similar after 3 months. Unadjusted survival was superior with SAVR but comparable when
adjusted for age and comorbidities. Whether TAVR is a suitable substitute for SAVR in patients
with anticipated PPM warrants additional investigation.1900 Is commissural closure associated with mitral annuloplasty a durable
technique for the treatment of mitral regurgitation? A long-term (#15 years)
clinical and echocardiographic study
Michele De Bonis, MD, Elisabetta Lapenna, MD, Maurizio Taramasso, MD, Alberto Pozzoli, MD,
Giovanni La Canna, MD, Maria Chiara Calabrese, MD, and Ottavio Alfieri, MD, Milan, ItalyThe aim of the present study was to assess the long-term clinical and echocardiographic outcomes
of paracommissural edge-to-edge for MR due to commissural prolapse or flail. At 11 years, the
freedom from MR grade 3+ or greater was 96.3% 6 1.7%. Commissural closure repair combined
with annuloplasty provides excellent long-term results in patients with MR due to commissural
lesions.)






L1907 Valve replacement surgery for older individuals with preoperative atrial
fibrillation: The effect of prosthetic valve choice and surgical ablation(continued on page 16A
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 6 15AHo Jin Kim, MD, Joon Bum Kim, MD, PhD, Sung-Ho Jung, MD, Suk Jung Choo, MD, PhD,
Cheol Hyun Chung, MD, PhD, and Jae Won Lee, MD, PhD, Seoul, Republic of KoreaD
CHWe evaluated 573 patients aged 60 years or older with atrial fibrillation undergoing valve
replacement surgery. The survival was affected by several baseline characteristics and the
performance of surgical atrial fibrillation ablation but not by the choice of prosthesis. These
findings suggest that atrial fibrillation ablation should be considered.Perioperative
Management (PM)
1918 Use of argatroban: Experiences in continuous renal replacement therapy in
critically ill patients after cardiac surgeryG
TSMatthias Klingele, MD, Hagen Bomberg, MD, Anne Lerner-Gr€aber, MD, Danilo Fliser, MD,
Aaron Poppleton, MD, Hans J. Sch€afers, MD, and Heinrich V. Groesdonk, MD, Homburg/Saar,
GermanyArgatroban provides effective anticoagulation for dialysis. It has been proposed that the risk for
bleeding complications might be greater with argatroban than with heparin in critically ill patients
after cardiac surgery. Close monitoring and dose titration result in a comparable risk of bleeding
regardless of the underlying disease severity.1D925 Weight-based versus set dosing of vancomycin for coronary artery bypass
grafting or aortic valve surgeryC
AMatthew J. Hafermann, PharmD, Tyree H. Kiser, PharmD, Clark Lyda, PharmD,
Douglas N. Fish, PharmD, Gerard R. Barber, RPh, MPH, Michael F. Wempe, PhD, and
Joseph C. Cleveland, Jr, MD, Seattle, Wash, and Aurora, ColoThis study aimed to identify the optimal dosing strategy of vancomycin in patients undergoing
cardiac surgery requiring cardiopulmonary bypass. Aweight-based dosing strategy of vancomycin
at 20 mg/kg was found to more consistently result in vancomycin concentrations greater than
15 mg/mL throughout surgery than a standard 1-g dosing strategy.1931 Penicillin skin testing in cardiac surgery MPDavid J. Cook, MD, David W. Barbara, MD, Karen E. Singh, MD, and Joseph A. Dearani, MD,
Rochester, Minn, and Charlottesville, VaIn this retrospective study of 8914 patients, 276 patients with penicillin or cephalosporin allergies
underwent skin testing. Testing demonstrated a true allergy incidence of 0.9%. True penicillin
allergy is quite rare and preoperative allergy testing reduces unnecessary vancomycin
administration in those tested.S
Evolving Technology/
Basic Science (ET/BS)
1936 Clinical results of microfluidic antibody-independent peripheral blood
circulating tumor cell capture for the diagnosis of lung cancerET
/BEric Lim, MD, FRCS, Andee Tay, BSc, Jan Von Der Thusen, MD, PhD, Maxim B. Freidin, PhD,
Vladimir Anikin, MD, FRCS, and Andrew G. Nicholson, DM, FRCPath, London, United KingdomThe ability to capture and characterize peripheral blood circulating tumor cells has the potential for
the development of a blood test for cancer. The aim of this study was to evaluate the diagnostic
performance of microfluidic technology as a proof-of-concept study.)
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TX116A The Journal of Thoracic an939 Aprotinin, but not 3-aminocaproic acid and tranexamic acid, exerts
neuroprotection against excitotoxic injury in an in vitro neuronal cell
culture model(continued on page 17A
d Cardiovascular Surgery c June 2014Zhaohui Lu, MD, Ludmila Korotcova, MD, Akira Murata, MD, Nobuyuki Ishibashi, MD, and
Richard A. Jonas, MD, Washington, DC, and Shanghai, ChinaAprotinin is neuroprotective through suppression of excitotoxicity-mediated neuronal degeneration
in an in vitro neuronal cell culture model. In contrast, 3-aminocaproic acid and tranexamic acid
exerts no neuroprotection against excitotoxic injury that can occur during cardiac surgery.1946 BRCA1 shields vascular smooth muscle cells from oxidative stress
Fina Lovren, PhD, Yi Pan, MD, Adrian Quan, MPhil, Krishna K. Singh, PhD, Rishad Khan,
Nandini Gupta, MD, Christine Brezden-Masley, MD, PhD, Hwee Teoh, PhD,
Mark D. Wheatcroft, BSc, MBChB, MD, Mohammed Al-Omran, MD, MSc, and
Subodh Verma, MD, PhD, Ottawa and Toronto, Ontario, CanadaThe potential of BRCA1 to regulate reactive oxygen species production is explored. This study
shows that BRCA1 protects VSMCs against oxidative stress via downregulation of key NADPH
oxidase subunits. BRCA1-based gene therapy reduces blood pressure in a hypertensive model in
part through the NADPH system.1956 Role of myocardial hypertrophy on acute and chronic right ventricular
performance in relation to chronic volume overload in a porcine model:
Relevance for the surgical management of tetralogy of Fallot
Thierry Bove, MD, Kristof Vandekerckhove, MD, Stefaan Bouchez, MD,
Patrick Wouters, MD, PhD, Pamela Somers, MSc, PhD, and
Guido Van Nooten, MD, PhD, Ghent, BelgiumUsing conductance technology, we showed that hypertrophy attenuates RV-remodeling related to
chronic volume-overload by pulmonary insufficiency. It enables better preservation of contractility
but at the cost of sustained diastolic impairment. These findings might elucidate on timing and
strategy for TOF repair when RVOT morphology indicates a need for transannular reconstruction.Cardiothoracic
Transplantation (TX)
1966 Continuous flow left ventricular assist device technology has influenced wait
times and affected donor allocation in cardiac transplantation
Sharven Taghavi, MD, MPH, Senthil N. Jayarajan, MD, MS, Eugene Komaroff, PhD, and
Abeel A. Mangi, MD, Philadelphia, Pa, and New Haven, ConnThe UNOS database was examined to determine the influence of cfLVAD on waitlist times and
organ allocation. Despite being less favorable recipients, patients with cfLVAD spent more time in
status 1A and had greater waitlist survival. This might allow cfLVAD patients to obtain more
preferable donors.1972 Preoperative risk factors predict survival following cardiac retransplantation:
Analysis of the United Network for Organ Sharing database
Erol Belli, MD, Juan Carlos Leoni Moreno, MD, Jeffrey Hosenpud, MD,
Bhupendra Rawal, MS, and Kevin Landolfo, MD, Jacksonville, FlaPatients undergoing late cardiac retransplantation have an acceptable overall survival.
Perioperative factors associated with worse survival following late cardiac retransplantation
include age of the donor, ischemic time, age of the recipient, presence of extracorporeal membrane
oxygenator, and the number of days between the first and second transplant.)






LCardiothoracic Imaging 1978 A ‘‘leaking’’ aorta
Salomone Di Saverio, MD, Enrico Gallitto, MD, and Gregorio Tugnoli, MD, Bologna, Italy(continued on page 18A
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 6 17ASurgical Techniques 1982 HVAD continuous flow assist device for ischemic ventricular septal rupture H
DCAlexander M. Bernhardt, MD, Hermann Reichenspurner, MD, PhD, and
Tobias Deuse, MD, Hamburg, Germany1984 Bilateral pulmonary artery banding with ligation clips: A novel technique
resistant to residual stenosis
Yukihiro Kaneko, PhD, Ikuya Achiwa, MD, Hiroyuki Morishita, MD, and
Miyuki Shibata, MD, Tokyo, Japan1986 Reconstruction of the sternal manubrium TS
GJarosław Ku_zd_zał, MD, PhD, FETCS, Janusz Warmus, MD, PhD,
Zbigniew Grochowski, MD, PhD, and Artur Ga˛dek, MD, PhD, Cracow, Poland1988 Novel repair of a defect in the cervical trachea with a thymus pedicle flap
Kimihiro Shimizu, MD, PhD, Toshiteru Nagashima, MD, Yoichi Ohtaki, MD, PhD, and
Izumi Takeyoshi, MD, PhD, Maebashi, JapanABrief Research Report 1991 High Agatston aortic valve calcium score predicts transcatheter paravalvularaortic regurgitationCDKevin L. Greason, MD, Eric E. Williamson, MD, Rakesh M. Suri, MD, and
Verg Mathew, MD, Rochester, MinnOnline Only:
Case Reports
e67 Rupture of a coronary artery aneurysm in Kawasaki disease: A rare case and
review of the literature for the past 15 yearsPMTakashi Miyamoto, MD, PhD, Kentaro Ikeda, MD, Youichirou Ishii, MD, PhD, and
Tomio Kobayashi, MD, PhD, Gunma, Japane70 Concomitant phrenic nerve pacing and lobectomy in a patient with
quadriplegia
Faouzi Alimi, MD, Ciprian Pricopi, MD, Capucine Morelot-Panzini, MD, and
Franc¸oise Le Pimpec-Barthes, MD, PhD, Paris, FranceeB
S72 Left ventricular assist device thrombosis presenting as an acute coronary
syndrome
T/E
Navin K. Kapur, MD, Jenica Upshaw, MD, Michael S. Kiernan, MD, and
Duc Thinh Pham, MD, Boston, Masse74 Percutaneous pulmonary valve implantation after Ross-Konno
aortoventriculoplasty: A cautionary word
Syed Murfad Peer, MD, and Pranava Sinha, MD, Washington, DCeX76 An alternate approach to valve replacement in patients with mitral stenosis
and severely calcified annulusTSameh M. Said, MD, and Hartzell V. Schaff, MD, Rochester, Minn)














TXe18A The Journal of Thoracic an79 New 15-mL ventricular assist device in children with restrictive physiology
of the left ventricle(continued on page 19A
d Cardiovascular Surgery c June 2014Santosh Sundararajan, MD, Timothy Thiruchelvam, MB, ChB, Tain-Yen Hsia, MD, and
Ann Karimova, MD, London, United Kingdome80 Avoidance of completion pneumonectomy by sparing the right middle lobe
Thomas Fabian, MD, FCCP, and Jeremy W. Docekal, MD, Albany, NYe82 Extracorporeal membrane oxygenation as a bridge to surgery for ischemic
papillary muscle rupture
Benjamin Obadia, JD, Alexis Theron, MD, Vlad Gariboldi, MD, and Frederic Collart, MD,
Marseille, FranceLetters to the Editor 1992 Is it possible to expand a porcelain ring without breaking?
Murat Tavlasoglu, MD, Adem Guler, MD, and Mustafa Kurkluoglu, MD, Diyarbakir and
Ankara, Turkey, and Washington, DC1992 Reply to the Editor
Manuel Wilbring, MD, Sems-Malte Tugtekin, MD, and Utz Kappert, MD, Dresden, Germany1993 Which subgroup of mitral valve replacement should be compared with
mitral valve repair in concomitant aortic and mitral valve surgery?
Murat Tavlasoglu, MD, Adem Guler, MD, and Mustafa Kurkluoglu, MD, Diyarbakir and
Ankara, Turkey, and Washington, DC1994 Reply to the Editor
Gonc¸alo F. Coutinho, MD, Pedro M. Correia, MD, and Manuel J. Antunes, MD, PhD,
Coimbra, Portugal1995 Conversion from percutaneous venoarterial extracorporeal membrane
oxygenation access to a peripheral arterial cannulation: Is it safe?
Carlo Banfi, MD, PhD, FCCP, Karim Bendjelid, MD, PhD, and
Rapha€el Giraud, MD, MSc, Geneva, Switzerland1996 Reply to the Editor
Stefanos Demertzis, MD, Lugano and Bern, Switzerland1996 Reply to ‘‘Is the cause of death in hypertrophic cardiomyopathy low pressure
gradient in left ventricular outflow?’’
Hartzell Schaff, MD, Rochester, Minn1997 Should pulmonary lobectomy be replaced by sublobar resection in patients
with stage I non–small cell lung cancer?
Alessandro Baisi, MD, Matilde De Simone, MD, PhD, Ugo Cioffi, MD, PhD, and
Federico Raveglia, MD, PhD, Milan, Italy)






L1998 Relative amplitude index: A new tool for hemodynamic evaluation of
periprosthetic regurgitation after transcatheter valve implantation(continued on page 20A
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 6 19AMichael Poullis, BSc(Hons), MBBS, MD, FRCS(CTh), Liverpool, United Kingdom1999 Reply to the EditorH
DNikolaos Bonaros, MD, PhD, and Anneliese Heinz, MD, Innsbruck, AustriaC2000 Simple interrupted suturing for aortic valve replacement in a small aortic
annulus
Jong Hun Kim, MD, and Jong Bum Choi, MD, Jeonju, South KoreaNotice of Correction 2TS001 Correction of article by Khalpey Z, Sydow N, Slepian MJ, Poston R, entitled
How to do it: Thoracoscopic left ventricular assist device implantation using
robot assistance (2014;147:1423-5).GAnnouncements The American Association for Thoracic Surgery2002 Heart Valve Summit 20142002 AATS Award Applications2002 New in 2014—Save the DateCDThe American Association for Thoracic Surgery JournalsA2003 Seminars in Thoracic and Cardiovascular SurgeryThe Western Thoracic Surgical Association2003 WTSA 40th Annual MeetingThe AATS Graham Research FoundationM2004 In Its 40th Year, the AATS Graham Foundation Announces New Specialty ProgramsPThe American Board of Thoracic Surgery2004 Notices2004 Requirements for Maintenance of CertificationB
ST/E
Thoracic Surgery Foundation for Research and Education and Women in
Thoracic Surgery2005 Carolyn E. Reed Traveling Fellowship2005 Thoracic Surgery Foundation for Research and Education)
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